Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.


Date Title Topic
23 Apr 2013 New research characterises effectiveness and variability in patient recruitment and retention practices Bioethics, legal and economic issues
22 Apr 2013 Cancer cachexia in the era of obesity Palliative and supportive care
17 Apr 2013 Novel AKT pathway inhibitor, ARQ 092, demonstrates safety, effective target inhibition Anticancer agents & Biologic therapy
17 Apr 2013 AKT inhibitor AZD5363 well tolerated, yielded partial response in some patients with advanced solid tumours Anticancer agents & Biologic therapy
15 Apr 2013 Are the elderly excluded from practice-changing trials in advanced NSCLC? Cancer in Special Situations - Lung and other thoracic tumours
15 Apr 2013 European Medicines Agency publishes report on patient recruitment and geographical location of clinical trials Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
10 Apr 2013 Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced peripheral neuropathy Palliative and supportive care
10 Apr 2013 Relationship between tumour biomarkers and efficacy in EMILIA trial identified women most likely to benefit from T-DM1 Breast cancer - Personalised medicine
10 Apr 2013 Third-generation device significantly improves capture of circulating tumour cells Translational research
10 Apr 2013 Biomarker subanalysis of the phase III study of regorafenib vs placebo in TKI-refractory metastatic GIST Translational research - Sarcomas
08 Apr 2013 New ESMO web site: spring is in the air!
08 Apr 2013 Comprehensive genomic analysis of squamous cell carcinoma of the head and neck Pathology/Molecular biology - Translational research - Head and neck cancers
04 Apr 2013 An analysis suggests large disparity in the availability and organisation of radiotherapy services between European countries Bioethics, legal and economic issues
04 Apr 2013 Is adjuvant trastuzumab cost-effective for HER2-positive T1bN0 breast cancer? Breast cancer - Bioethics, legal and economic issues
02 Apr 2013 Determining the prevalence of ROS1 fusions in Chinese patients with non-small cell lung cancer Lung and other thoracic tumours